e-Drug3D 775 |
CABERGOLINE
|
cas 81409-90-7 |
CLASS NERVOUS SYSTEM |
ROUTE (list) ORAL |
PK parameters Tmax 2.5 HOUR Solubility INSOLUBLE IN WATER |
Target TARGET D(2) DOPAMINE RECEPTOR |
DrugCentral D(2) dopamine receptor UNIPROT P14416 DRD2 |
Download SDF file | N-[3-(Dimethylamino)propyl]-N-[(ethylamino)carbonyl]- 6-(2-propenyl)-8g-ergoline-8-carboxamide Formula: Calculated chemical properties: MW 451.61 NB_atoms 33 XLogP 3.19 PSA 66.177 NB_HD 2 NB_HA 7 fsp3 0.54 Lipinski(0=no;1=yes) 1 |
FDA NDA 020664 (pdf not found) INN (CABERGOLINE) DOSTINEX (PFIZER) APPROVAL= AP YEAR= 1996 NEWMOLECULARENTITY DISCONTINUED NDA 076310 (pdf not found) INN (CABERGOLINE) CABERGOLINE (STRIDES PHARMA) APPROVAL= AP YEAR= 2005 NDA 077750 (pdf not found) INN (CABERGOLINE) CABERGOLINE (IVAX SUB TEVA PHARMS) APPROVAL= AP YEAR= 2007 NDA 077843 (pdf not found) INN (CABERGOLINE) CABERGOLINE (IMPAX LABS INC) APPROVAL= AP YEAR= 2007 DISCONTINUED NDA 078035 (pdf not found) INN (CABERGOLINE) CABERGOLINE (ACTAVIS LABS FL INC) APPROVAL= AP YEAR= 2008 DISCONTINUED NDA 201503 (pdf not found) INN (CABERGOLINE) CABERGOLINE (APOTEX CORP) APPROVAL= AP YEAR= 2013 DISCONTINUED NDA 202947 (pdf not found) INN (CABERGOLINE) CABERGOLINE (PHARMOBEDIENT) APPROVAL= AP YEAR= 2013 DISCONTINUED NDA 204735 (pdf not found) INN (CABERGOLINE) CABERGOLINE (INGENUS PHARMS LLC) APPROVAL= AP YEAR= 2018 NDA 218109 (pdf not found) INN (CABERGOLINE) CABERGOLINE (SOMERSET THERAPS LLC) APPROVAL= AP YEAR= 2024 NDA 218618 (pdf not found) INN (CABERGOLINE) CABERGOLINE (SKG PHARMA) APPROVAL= AP YEAR= 2024 |
Other links: |